Veru (NASDAQ: VERU) launches $21.8M at-the-market common stock offering
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Veru Inc. entered into a Sales Agreement with Oppenheimer & Co. Inc. and Canaccord Genuity LLC that allows it to issue and sell, from time to time, up to $21,800,000 of its common stock through an at-the-market offering program.
Sales will be made under Veru’s effective Form S-3 shelf registration, using a base prospectus and a prospectus supplement filed on July 2, 2026. Each sales agent will use commercially reasonable efforts to execute trades based on Veru’s instructions, and Veru will pay a 3.0% commission on aggregate gross proceeds, plus certain expenses, and provide customary indemnification.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 1.01, 9.01
2 items
Item 1.01
Entry into a Material Definitive Agreement
Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
ATM capacity: $21,800,000 of common stock
Sales agent commission: 3.0% of gross proceeds
Shelf registration: Form S-3 File No. 333-294911
+1 more
4 metrics
ATM capacity
$21,800,000 of common stock
Maximum aggregate offering amount under Sales Agreement
Sales agent commission
3.0% of gross proceeds
Commission on each sale of common stock
Shelf registration
Form S-3 File No. 333-294911
Registration statement effective April 15, 2026
Prospectus supplement filing date
July 2, 2026
Related prospectus supplement for ATM program
Key Terms
Sales Agreement, at the market offering, Registration Statement on Form S-3, prospectus supplement, +1 more
5 terms
Sales Agreement financial
"Veru Inc. entered into a Sales Agreement with Oppenheimer & Co. Inc. and Canaccord Genuity LLC"
A sales agreement is a written contract that sets out the terms for selling goods, services, or assets, specifying price, delivery, payment schedule and responsibilities of each side. For investors it matters because it creates a predictable stream of revenue or cash obligations, clarifies timing and risk, and can change a company’s value or forecasts much like a signed order turns a customer’s verbal intent into a firm commitment.
at the market offering financial
"the Designated Sales Agent may sell the Common Stock by any method permitted by law deemed to be an “at the market offering”"
An at-the-market offering is a way a company raises cash by selling newly issued shares directly into the open market at prevailing prices, rather than all at once in a single deal. Think of it like turning a faucet on to drip shares into trading at current prices when needed; it gives the company flexibility to raise funds over time but can dilute existing shareholders and potentially affect the stock price, which investors should monitor.
Registration Statement on Form S-3 regulatory
"registered pursuant to the Company’s Registration Statement on Form S-3 (File No. 333-294911)"
A registration statement on Form S‑3 is a short, standardized filing a qualified public company uses to register new securities with regulators so they can be sold to investors; think of it as a pre-approved, reusable permission slip that speeds up future offerings. It matters to investors because it lets the company raise money more quickly and cheaply — which can fund growth or pay debt — but may also lead to share dilution or change in ownership, so it affects value and liquidity.
prospectus supplement regulatory
"which includes a base prospectus and a related prospectus supplement that was filed"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
indemnification and contribution financial
"has agreed to provide the Sales Agents with customary indemnification and contribution rights"
FAQ
What capital raising program did VERU announce in this 8-K filing?
Veru Inc. established an at-the-market offering program allowing it to sell up to $21,800,000 of common stock through Oppenheimer & Co. Inc. and Canaccord Genuity LLC, giving the company flexible access to equity financing as market conditions and its needs evolve.
How much common stock can Veru Inc. (VERU) sell under the new Sales Agreement?
Veru may offer and sell up to $21,800,000 of its common stock under the Sales Agreement. These sales occur from time to time through designated sales agents, using Veru’s effective Form S-3 shelf registration and related prospectus supplement filed on July 2, 2026.
Who are the sales agents in Veru Inc.’s at-the-market offering program?
Oppenheimer & Co. Inc. and Canaccord Genuity LLC act as sales agents for Veru’s at-the-market program. Either firm can serve as the Designated Sales Agent, using commercially reasonable efforts to sell Veru’s common stock according to the company’s price, time, and size instructions.
What commission will VERU pay on sales under the Sales Agreement?
Veru will pay the Designated Sales Agent a commission of 3.0% of the aggregate gross proceeds from each common stock sale. In addition, Veru agreed to reimburse specified expenses and provide customary indemnification and contribution protections under U.S. securities law frameworks.
Under what registration statement is VERU’s at-the-market offering registered?
The at-the-market offering is registered under Veru’s Registration Statement on Form S-3, File No. 333-294911. This shelf registration became effective on April 15, 2026 and is accompanied by a base prospectus and a related prospectus supplement filed on July 2, 2026.